IMERYS (EPA:NK) | Finanzwire

Basculer en Français

8296	Companies
114905	Keywords
55332	Articles
62461	Press releases

Home
Companies
IMERYS

REGULATED PRESS RELEASE

published on 09/26/2024 at 17:47, 1 month 24 days ago

imerys-26-September-2024-information-share-capital-and-voting-rights-as-of-31-August-2024
Imerys discloses number of outstanding shares and voting rights as of 31 August 2024, in compliance with regulations. The leading supplier of mineral-based specialty solutions reports revenue of €3.8 billion in 2023 and emphasizes commitment to sustainability

Voting Rights Sustainability Outstanding Shares Imerys Mineral-Based Solutions
BRIEF

published on 09/16/2024 at 18:05, 2 months 4 days ago

Imerys Reports Share Capital and Voting Rights as of 31 July 2024

Voting Rights Outstanding Shares Imerys Mineral-Based Solutions 2024 Update
REGULATED PRESS RELEASE

published on 09/16/2024 at 18:00, 2 months 4 days ago

imerys-16-September-2024-information-share-capital-and-voting-rights-as-of-31-July-2024
Imerys, leading mineral-based solutions supplier with €3.8b revenue & 13,700 employees, releases outstanding share & voting rights data as of 31 July 2024

Voting Rights Outstanding Shares Financial Disclosure Imerys Mineral-Based Solutions
BRIEF

published on 07/31/2024 at 18:05, 3 months 20 days ago

Half-yearly review of the IMERYS liquidity contract as of June 30, 2024

Liquidity Contract 2024 Imerys Stock Transactions BNP Paribas Arbitration
BRIEF

published on 07/31/2024 at 18:05, 3 months 20 days ago

Imerys Reports Share Capital and Voting Rights for June 2024

Share Capital Voting Rights Financial Disclosure Imerys June 2024
REGULATED PRESS RELEASE

published on 07/31/2024 at 18:00, 3 months 20 days ago

imerys-31-july-2024-information-share-capital-and-voting-rights-as-of-30-june-2024
Imerys discloses the number of outstanding shares and voting rights as of 30 June 2024, in compliance with regulatory requirements. The leading mineral-based specialty solutions supplier aims for sustainable growth and innovation

Voting Rights Outstanding Shares Sustainable Growth Imerys Mineral-Based Solutions
REGULATED PRESS RELEASE

published on 07/29/2024 at 17:47, 3 months 22 days ago

Imerys-press-release-H1-2024-results-29-July-2024-VENG
BRIEF

published on 07/10/2024 at 18:05, 4 months 10 days ago

Imerys Updates 3 Billion Euros EMTN Programme

Imerys Prospectus Financial Update EMTN Programme Luxembourg Stock Exchange
REGULATED PRESS RELEASE

published on 07/10/2024 at 18:00, 4 months 10 days ago

imerys-10-07-2024-regulated-information-update-of-the-EMTN-programme-for-2024
Imerys updates 3 billion euros EMTN programme prospectus approved by CSSF. Company offers mineral-based solutions to industries worldwide

Imerys Prospectus Mineral-Based Solutions EMTN Programme CSSF
BRIEF

published on 07/08/2024 at 08:35, 4 months 13 days ago

Imerys Completes Disposal of Paper Market Assets

Financial Performance Imerys Strategic Repositioning Paper Market Asset Disposal

Accesswire

Published on 11/21/2024 at 13:30, 33 minutes ago

AirIQ Announces September 30, 2024 Quarterly Results Company Reports Double-Digit Growth in Recurring Revenue
Published on 11/21/2024 at 13:30, 33 minutes ago

Datametrex Secures Additional P.O. Approx $250K for IT Services
Published on 11/21/2024 at 13:00, 1 hour 3 minutes ago

Aclara Secures Funding from Corfo's Innovation High-Tech Program for Artificial Intelligence Project
Published on 11/21/2024 at 13:00, 1 hour 3 minutes ago

Telomir Pharmaceuticals Confirms Age Reversal, Increased Longevity and Improved Healthspan in Groundbreaking Preclinical Study with Telomir-1
Published on 11/21/2024 at 13:00, 1 hour 3 minutes ago

Toggle3D.ai Rebrands as FOTOgpt.ai to Usher in a New Age of AI-Powered Photography

View all ACCESSWIRE

EQS Group

Published on 11/21/2024 at 13:15, 48 minutes ago

NOTICE OF ANNUAL GENERAL MEETING
Published on 11/21/2024 at 12:35, 1 hour 28 minutes ago

audius with successful third quarter 2024 - total revenue grows by +9.2% and EBITDA by +14.6
Published on 11/21/2024 at 12:15, 1 hour 48 minutes ago

Hardman & Co Investor Forum Research on Shield Therapeutics (STX): Proactive cash management to cashflow-breakeven
Published on 11/21/2024 at 12:06, 1 hour 57 minutes ago

IVU AG publishes Quarterly Report Q3-2024
Published on 11/21/2024 at 12:00, 2 hours 3 minutes ago

Holding(s) in Company

Les Echos

Published on 11/21/2024 at 06:58, 7 hours 5 minutes ago

Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/20/2024 at 19:20, 18 hours 43 minutes ago

Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting
Published on 11/20/2024 at 17:45, 20 hours 18 minutes ago

MEDESIS PHARMA HAS COMPLETED ITS CLINICAL STUDY FOR THE TREATMENT OF ALZHEIMER'S DISEASE WITH NANOLITHIUM
Published on 11/20/2024 at 17:45, 20 hours 18 minutes ago

Disclosure of Share Capital and Voting Rights Outstanding as of October 31, 2024
Published on 11/20/2024 at 07:45, 1 day 6 hours ago

Gimv sells to Fremman Capital a majority stake in outpatient rehabilitation specialist rehaneo

View all LES ECHOS COMFI WIRE